|
|
Present
DH., Serologic tests are not helpful in managing inflammatory bowel
disease.
Inflamm Bowel Dis. 2002 May;8(3):227-9; discussion 223, 230-1. |
|
Sandborn
WJ, Feagan BG, Hanauer SB, Lochs H, Lofberg R, Modigliani R, Present DH,
Rutgeerts P, Scholmerich J, Stange EF, Sutherland LR., A review of
activity indices and efficacy endpoints for clinical trials of medical
therapy in adults with Crohn's disease. Gastroenterology. 2002
Feb;122(2):512-30. Review. |
|
Haralambou
G,
Teirstein
AS
, Gil J,
Present DH, Bronchiolitis obliterans in a patient with ulcerative
colitis receiving mesalamine. Mt Sinai J Med. 2001
Nov;68(6):384-8. |
|
Persley
KM, Present DH, Neutropenia is not required for clinical remission
during azathioprine therapy in inflammatory bowel disease. Eur J
Gastroenterol Hepatol. 2001 Sep;13(9):1053-5. Review. |
|
Present
DH., Infliximab therapy for ulcerative colitis: many unanswered
questions. Am J Gastroenterol. 2001 Aug;96(8):2294-6. |
|
IBD Watch®
